Unknown

Dataset Information

0

Inorganic nitrate supplementation enhances functional capacity and lower-limb microvascular reactivity in patients with peripheral artery disease.


ABSTRACT: Peripheral artery disease (PAD) is characterized by functional and vascular impairments as well as elevated levels of inflammation which are associated with reduced nitric oxide (NO) bioavailability. Inorganic nitrate supplementation boosts NO bioavailability potentially improving functional and vasodilatory capacities and may reduce inflammation. Twenty-one patients with PAD were randomly assigned to sodium nitrate (NaNO3) or placebo supplementation groups for eight-weeks. Outcome measures included a 6-min walk test (6?MWT), blood flow and vasodilator function in the forearm and calf, as well as plasma inflammatory and adhesion biomarker concentrations. NaNO3 elevated plasma nitrate (32.3?±?20.0 to 379.8?±?204.6??M) and nitrite (192.2?±?51.8 to 353.1?±?134.2?nM), improved 6?MWT performance (387?±?90 to 425?±?82?m), peak calf blood flow (BFPeak; 11.6?±?4.9 to 14.1?±?5.1?mL/dL?tissue/min), and peak calf vascular conductance (VCPeak; 11.1?±?4.3 to 14.2?±?4.9?mL/dL?tissue/min/mmHg) (p?

SUBMITTER: Bock JM 

PROVIDER: S-EPMC6239203 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Inorganic nitrate supplementation enhances functional capacity and lower-limb microvascular reactivity in patients with peripheral artery disease.

Bock Joshua M JM   Treichler David P DP   Norton Samuel L SL   Ueda Kenichi K   Hughes William E WE   Casey Darren P DP  

Nitric oxide : biology and chemistry 20180815


Peripheral artery disease (PAD) is characterized by functional and vascular impairments as well as elevated levels of inflammation which are associated with reduced nitric oxide (NO) bioavailability. Inorganic nitrate supplementation boosts NO bioavailability potentially improving functional and vasodilatory capacities and may reduce inflammation. Twenty-one patients with PAD were randomly assigned to sodium nitrate (NaNO<sub>3</sub>) or placebo supplementation groups for eight-weeks. Outcome me  ...[more]

Similar Datasets

| S-EPMC9718944 | biostudies-literature
| S-EPMC6048463 | biostudies-literature
| S-EPMC5989435 | biostudies-literature
| S-EPMC6682431 | biostudies-literature
| S-EPMC7525944 | biostudies-literature
| S-EPMC3971856 | biostudies-literature
| S-EPMC9062890 | biostudies-literature
| S-EPMC6474956 | biostudies-literature
| S-EPMC5823250 | biostudies-literature
| S-EPMC8409914 | biostudies-literature